MAN vs TBI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

MAN

61.9
AI Score
VS
MAN Wins

TBI

58.5
AI Score

Investment Advisor Scores

MAN

Oct 02, 2026
62score
Recommendation
HOLD

TBI

Oct 02, 2026
59score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric MAN TBI Winner
Forward P/E 11.7647 11.2994 TBI
PEG Ratio 0.943 0.8068 TBI
Revenue Growth 7.5% 11.8% TBI
Earnings Growth -58.2% -63.4% MAN
Tradestie Score 61.9/100 58.5/100 MAN
Profit Margin 0.6% -3.4% MAN
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

MAN 1M: -10.6% · 3M: +40.2% TBI 1M: -10.3% · 3M: +12.0%

Current Technical Phase

MAN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 36.5 · Price: $53.90

TBI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.7 · Price: $9.15

Fundamentals Snapshot

Metric MAN TBI
Market Cap — —
Forward P/E 11.6 11.6
Trailing P/E 25.5 —
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.2% 0.2%
Operating Margin 0.0% 0.0%
EPS 2.18 -1.92
Dividend Yield 0.03% —

Frequently Asked Questions

Based on our detailed analysis, MAN is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.